Liquan Xue
- Immunology top 5%
- Immune Cell Function and Interaction 7
- Immune Response and Inflammation 7
- T-cell and Retrovirus Studies 2
- Cancer Research top 5%
- NF-κB Signaling Pathways 9
-
- Lymphoma Diagnosis and Treatment 5
- Oncology top 5%
- Lung Cancer Research Studies 2
- Genetics top 10%
-
- Lung Cancer Treatments and Mutations 4
-
- Cancer therapeutics and mechanisms 2
Liquan Xue
26 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 95
- Immunology 756
- Cancer Research 478
- Pathology and Forensic Medicine 460
- Oncology 543
- Genetics 134
Countries citing papers authored by Liquan Xue
This map shows the geographic impact of Liquan Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liquan Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liquan Xue more than expected).
Fields of papers citing papers by Liquan Xue
This network shows the impact of papers produced by Liquan Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liquan Xue. The network helps show where Liquan Xue may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liquan Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2013 | 174 | |
| 3 | 2013 | 5 | |
| 4 | 2013 | 1 | |
| 5 | 2013 | 48 | |
| 6 | 2011 | 76 | |
| 7 | 2011 | 80 | |
| 8 | 2009 | 183 | |
| 9 | 2009 | 46 | |
| 10 | 2008 | 49 | |
| 11 | 2008 | 13 | |
| 12 | 2007 | 24 | |
| 13 | 2007 | 272 | |
| 14 | 2006 | 80 | |
| 15 | 2003 | 36 | |
| 16 | 2003 | 17 | |
| 17 | 2002 | 220 | |
| 18 | 2001 | 92 | |
| 19 | 1999 | 303 | |
| 20 | 1999 | 8 |
About Liquan Xue
Liquan Xue is a scholar working on Immunology, Cancer Research and Immunology and Allergy, having authored 26 papers that have together received 1.9k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (9 papers), Immune Cell Function and Interaction (7 papers), Immune Response and Inflammation (7 papers), Lymphoma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (4 papers), T-cell and Retrovirus Studies (2 papers), Lung Cancer Research Studies (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Immunology (756 citations), Cancer Research (478 citations) and Pathology and Forensic Medicine (460 citations). Liquan Xue has collaborated with scholars based in United States, China and Austria. Frequent co-authors include Stephan W. Morris, Renren Wen, Xiaoli Cui, Demin Wang, Qin Jiang, Carlos J. Orihuela, Elaine Tuomanen, Tomasz Skórski, Mirosław Majewski and Mariusz A. Wasik. Their work appears in journals such as The Journal of Immunology, Journal of Biological Chemistry, Nature Immunology, Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.